» Authors » Mary K Ziejewski

Mary K Ziejewski

Explore the profile of Mary K Ziejewski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 39
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stokes A, Franklin K, Fisher D, Posobiec L, Binazon O, Tripathi N, et al.
Int J Toxicol . 2021 Feb; 40(2):125-142. PMID: 33517807
Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infections, and vaccines are needed to treat young children and older adults. One of GSK's candidate vaccines...
2.
Stanislaus D, Posobiec L, Laffan S, Solomon H, Ziejewski M, Romach E
Birth Defects Res . 2019 Dec; 112(3):245-261. PMID: 31859466
The success of new antiretroviral medicines for HIV resulted in a change to guidelines of standard therapy where continuation of antiretroviral therapy is recommended to maintain the low viral load...
3.
Picut C, Ziejewski M, Stanislaus D
Birth Defects Res . 2017 Oct; 110(3):190-227. PMID: 29063715
This review describes pre- and postnatal development of the male reproductive system in humans and laboratory animals, and highlights species differences in the timing and control of hormonal and morphologic...
4.
Ziejewski M, Solomon H, Rendemonti J, Stanislaus D
Birth Defects Res B Dev Reprod Toxicol . 2015 Feb; 104(1):23-34. PMID: 25704050
Background: There are two methods used when examining fetal rabbit eyes and brain in teratology studies. One method employs prior fixation before serial sectioning (Wilson's technique) and the other uses...
5.
Ziejewski M, Vidal J, Stanislaus D, Apostoli A, Chowdhury P, Laffan S
Birth Defects Res B Dev Reprod Toxicol . 2013 Jan; 98(1):63-71. PMID: 23348917
Background: In a repeat oral dose toxicity study, all of 16 male rats given 100 mg/kg/day GSK1322888 sustained testicular injury after 4 weeks of treatment; the findings were not reversible...
6.
Ziejewski M, Solomon H, Stanislaus D, Clark R, White T, Apostoli A
Birth Defects Res B Dev Reprod Toxicol . 2011 Dec; 95(1):54-62. PMID: 22127931
Background: Casopitant is a potent and selective NK-1 receptor antagonist that has shown clinical efficacy in the prevention of chemotherapy-induced and postoperative-induced nausea and vomiting. Methods: In an embryo-fetal development...